Researcher profile

Amin Khademi

Amin Khademi contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2021arXiv

Rolling Horizon Policies in Multistage Stochastic Programming

Multistage Stochastic Programming (MSP) is a class of models for sequential decision-making under uncertainty. MSP problems are known for their computational intractability due to the sequential nature of the decision-making structure and the uncertainty in the problem data due to the so-called curse of dimensionality. A common approach to tackle MSP problems with a large number of stages is a rolling-horizon (RH) procedure, where one solves a sequence of MSP problems with a smaller number of stages. This leads to a delicate issue of how many stages to include in the smaller problems used in the RH procedure. This paper addresses this question for, both, finite and infinite horizon MSP problems. For the infinite horizon case with discounted costs, we derive a bound which can be used to prescribe an epsilon-sufficient number of stages. For the finite horizon case, we propose a heuristic approach from the perspective of approximate dynamic programming to provide a sufficient number of stages for each roll in the RH procedure. Our numerical experiments on a hydrothermal power generation planning problem show the effectiveness of the proposed approaches.

preprint2020arXiv

Data-Driven Infectious Disease Control with Uncertain Resources

We study a resource allocation problem for containing an infectious disease in a metapopulation subject to resource uncertainty. We propose a two-stage model where the policy maker seeks to allocate resources in both stages where the second stage resource is random. Instead of a system of nonlinear differential equations that governs the epidemic trajectories in the constraints of the optimization model, we use a data-driven functional form to model the cumulative number of infected individuals. This flexible data-driven modeling choice allows us to transform the optimization problem to a tractable mixed integer linear program. Our flexible approach can handle an online decision making process, where the decision makers update their decisions for opening treatment units and allocating beds utilizing the new information about the epidemic progress. We utilize a detailed simulation model, validated by real data from the 2014 Ebola epidemic in Sierra Leone. Our results show that our policies produce about 400 fewer number of infected individuals in Sierra Leone compared to the policies applied during the actual epidemic. We also provide a detailed comparison of allocation policies generated by our optimization framework which sheds light on the optimal resource allocation in different regions.

preprint2020arXiv

Robust Optimal Design of Two-Armed Trials with Side Information

Significant evidence has become available that emphasizes the importance of personalization in medicine. In fact, it has become a common belief that personalized medicine is the future of medicine. The core of personalized medicine is the ability to design clinical trials that investigate the role of patient covariates on treatment effects. In this work, we study the optimal design of two-armed clinical trials to maximize accuracy of statistical models where the interaction between patient covariates and treatment effect are incorporated to enable precision medication. Such a modeling extension leads to significant complexities for the produced optimization problems because they include optimization over design and covariates concurrently. We take a robust optimization approach and minimize (over design) the maximum (over population) variance of interaction effect between treatment and patient covariates. This results in a min-max bi-level mixed integer nonlinear programming problem, which is notably challenging to solve. To address this challenge, we introduce a surrogate model by approximating the objective function for which we propose two solution approaches. The first approach provides an exact solution based on reformulation and decomposition techniques. In the second approach, we provide a lower bound for the inner optimization problem and solve the outer optimization problem over the lower bound. We test our proposed algorithms with synthetic and real-world data sets and compare it with standard (re-)randomization methods. Our numerical analysis suggests that the lower bounding approach provides high-quality solutions across a variety of settings.